Alec B. Wilkens

2.0k total citations · 2 hit papers
4 papers, 1.5k citations indexed

About

Alec B. Wilkens is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Alec B. Wilkens has authored 4 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 2 papers in Oncology and 2 papers in Immunology. Recurrent topics in Alec B. Wilkens's work include CRISPR and Genetic Engineering (2 papers), CAR-T cell therapy research (2 papers) and RNA Interference and Gene Delivery (1 paper). Alec B. Wilkens is often cited by papers focused on CRISPR and Genetic Engineering (2 papers), CAR-T cell therapy research (2 papers) and RNA Interference and Gene Delivery (1 paper). Alec B. Wilkens collaborates with scholars based in United States. Alec B. Wilkens's co-authors include Rasmus O. Bak, Ayal Hendel, Matthew H. Porteus, Israel Steinfeld, Subhadeep Roy, Andrew Kennedy, Robert Kaiser, Anya Tsalenko, Joseph T. Clark and Daniel E. Ryan and has published in prestigious journals such as Nature, Blood and Nature Biotechnology.

In The Last Decade

Alec B. Wilkens

4 papers receiving 1.4k citations

Hit Papers

Chemically modified guide... 2015 2026 2018 2022 2015 2016 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alec B. Wilkens United States 3 1.3k 446 218 146 142 4 1.5k
Sruthi Mantri United States 6 1.4k 1.0× 593 1.3× 262 1.2× 153 1.0× 167 1.2× 9 1.6k
Mara Pavel-Dinu United States 9 1.9k 1.4× 766 1.7× 362 1.7× 214 1.5× 166 1.2× 16 2.1k
M. Kyle Cromer United States 11 992 0.7× 443 1.0× 255 1.2× 91 0.6× 46 0.3× 17 1.2k
Carmencita E. Nicolas United States 2 684 0.5× 314 0.7× 133 0.6× 82 0.6× 123 0.9× 2 776
Timothy Davis United States 12 768 0.6× 320 0.7× 367 1.7× 85 0.6× 69 0.5× 17 1.1k
Fabrizia Urbinati United States 17 1.1k 0.8× 785 1.8× 299 1.4× 73 0.5× 330 2.3× 28 1.4k
Carsten T. Charlesworth United States 7 854 0.6× 357 0.8× 157 0.7× 84 0.6× 44 0.3× 10 938
Giulia Schiroli United States 7 786 0.6× 501 1.1× 252 1.2× 46 0.3× 119 0.8× 14 955
Seok‐Jin Heo United States 13 942 0.7× 193 0.4× 121 0.6× 47 0.3× 113 0.8× 19 1.1k
Jiazhi Hu China 21 1.9k 1.5× 349 0.8× 255 1.2× 178 1.2× 35 0.2× 40 2.2k

Countries citing papers authored by Alec B. Wilkens

Since Specialization
Citations

This map shows the geographic impact of Alec B. Wilkens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alec B. Wilkens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alec B. Wilkens more than expected).

Fields of papers citing papers by Alec B. Wilkens

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alec B. Wilkens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alec B. Wilkens. The network helps show where Alec B. Wilkens may publish in the future.

Co-authorship network of co-authors of Alec B. Wilkens

This figure shows the co-authorship network connecting the top 25 collaborators of Alec B. Wilkens. A scholar is included among the top collaborators of Alec B. Wilkens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alec B. Wilkens. Alec B. Wilkens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

4 of 4 papers shown
1.
Wilkens, Alec B., Margot J. Pont, Gabriel O. Cole, et al.. (2022). NOTCH1 signaling during CD4+ T-cell activation alters transcription factor networks and enhances antigen responsiveness. Blood. 140(21). 2261–2275. 15 indexed citations
2.
Dever, Daniel P., Rasmus O. Bak, Andreas Reinisch, et al.. (2016). CRISPR/Cas9 β-globin gene targeting in human haematopoietic stem cells. Nature. 539(7629). 384–389. 641 indexed citations breakdown →
3.
Greenberg, Philip D., Kristin G. Anderson, Sunil R. Hingorani, et al.. (2016). Abstract IA01: Engineering T cell responses to tumors: Taking the immune system where no responses have gone before. Cancer Immunology Research. 4(11_Supplement). IA01–IA01. 1 indexed citations
4.
Hendel, Ayal, Rasmus O. Bak, Joseph T. Clark, et al.. (2015). Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary cells. Nature Biotechnology. 33(9). 985–989. 813 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026